Home›Stock Screener›Medplus Health Services

Medplus Health Services Share Price Today | Stock Price & Medplus Health Services Share Screener

MEDPLUS Pharmacy Retail
Live Share Price NSE
₹644.40
▼ -9.90 (-1.51%)
2026-10-05 00:00:00
Live Share Price BSE
₹643.95
▼ -10.40 (-1.59%)
2026-10-05 00:00:00

As of October 5, 2026, the live Medplus Health Services share price (NSE: MEDPLUS) is ₹644.40 on NSE and ₹643.95 on BSE, down 1.51% from the previous close, with shares trading between ₹640.10 and ₹655.55 in today's trading session, and a 52-week range of ₹644.40–₹953.90. Check MEDPLUS price range for the annual price range and momentum. Use the Medplus Health Services stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medplus Health Services opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,885 and net income of ₹64, with EBITDA of ₹190, an operating margin of 9.0% and a profit margin of 3.4%.

Medplus Health Services Market Cap ₹7,856.96 Cr.
MEDPLUS P/E Ratio (TTM) 37.06
Medplus Health Services P/B Ratio 3.95
EPS (TTM) ₹18.33
Dividend Yield -
Debt to Equity 0.68
MEDPLUS 52 Week High ₹953.90
Medplus Health Services 52 Week Low ₹644.40
Operating Margin 9.00%
Profit Margin 3.40%
MEDPLUS Revenue (TTM) ₹1,885.00
EBITDA ₹190.00
Net Income ₹64.00
Total Assets ₹3,933.00
Total Equity ₹1,975.00

Medplus Health Services Share Price Chart

Track the current stock price of Medplus Health Services with an interactive chart. Analyse MEDPLUS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medplus Health Services stock quote in one place.

The quote of ₹644.40 sits between the 52-week low of ₹644.40 and the 52-week high of ₹953.90, and the latest session moved -1.51% from the previous close.

Medplus Health Services Company Profile - Fundamental Screener

Screen Medplus Health Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDPLUS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Retail sector and the Pharmacy Retail industry, and it trades under ISIN INE804L01022.

Company Details

Classification

Sector Retail
Industry Pharmacy Retail
Sub-Sector Pharmacy Retail
Segment E

Identifiers and Leadership

ISIN INE804L01022

Medplus Health Services Balance Sheet Screener

Screen MEDPLUS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,933, up from ₹3,360 in 2025.

Latest statistics put total assets at ₹3,933 and shareholder funds at ₹1,975, with a leverage ratio of 0.68.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 3,933 3,360 3,005 2,797 2,594 1,566 1,349 673 644 538
Current Assets 2,069 1,844 1,568 1,481 1,632 923 816 475 458 397
Fixed Assets 1,595 1,296 1,242 1,138 799 517 420 90 84 81

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1,269 1,044 902 830 618 420 339 11 15 111
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,975 1,740 1,577 1,491 1,417 731 529 325 304 149
Share Capital 24 24 24 24 24 0 0 0 0 0
Reserves & Surplus 1,951 1,717 1,554 1,467 1,394 359 528 325 303 149

Medplus Health Services Income Statement Screener - Profit & Revenue Analysis

Screen Medplus Health Services income statement and profit fundamentals. Analyze MEDPLUS quarterly results. Medplus Health Services reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹1,885 and net profit was ₹64, equal to earnings per unit of ₹5.33, at an operating margin of 9%.

In that period expenses were ₹1,695, interest cost ₹34 and tax ₹16. The next period listed, 2026-Jun, shows revenue of ₹1,899 and net profit of ₹33.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 1,885 1,899 1,525 1,558 1,697 1,824 1,501 1,498 1,588 1,574 1,267 1,294 1,419 1,451 979
Expenses 1,695 1,746 1,373 1,412 1,531 1,648 1,385 1,395 1,452 1,429 1,171 1,213 1,324 1,350 914

Operating Costs and Margins

EBITDA 190 153 152 146 166 177 116 103 136 145 95 81 96 102 65
Operating Profit % 9.00% 7.00% 9.00% 8.00% 9.00% 9.00% 7.00% 6.00% 8.00% 8.00% 7.00% 6.00% 6.00% 6.00% 5.00%
Depreciation 76 78 64 66 69 73 59 60 63 63 56 52 56 57 34
Interest 34 33 27 27 29 31 25 25 25 26 22 23 24 25 19

Profit and Earnings

Profit Before Tax 80 42 61 53 69 73 32 18 48 57 17 5 16 20 13
Tax 16 9 10 10 13 16 -2 4 9 11 -9 1 2 6 1
Net Profit 64 33 51 42 56 58 34 14 39 46 27 4 15 14 11
EPS 5.33 2.76 4.32 3.54 4.63 4.82 2.81 1.20 3.24 3.84 2.24 0.32 1.22 1.15 0.99

Medplus Health Services Cash Flow Screener - Liquidity Fundamentals

Screen MEDPLUS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹496, and net cash flow was an inflow of ₹112.

Over the same period, investing activities used ₹128 and financing activities used ₹256.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 496 540 144 90 170 3 -7 147 32 34
Investing Activities -128 -318 -83 429 -703 -35 -28 -19 -18 -15

Financing and Net Cash

Financing Activities -256 -228 -198 -170 440 -6 90 -83 -1 -29
Net Cash Flow 112 -5 -137 350 -93 -37 56 45 14 -10

Medplus Health Services Shareholding Pattern Screener

See Medplus Health Services shareholding pattern with promoter, FII, and DII holdings. Check Medplus Health Services promoter holding and ownership changes for MEDPLUS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 40.22%, foreign institutions 15.53%, domestic institutions 27.82% and the public 11.82%, spread across 77,278 shareholders.

The shareholder count was 77,278 in 2026-Mar, compared with 76,005 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 40.22% 40.19% 40.34% 40.32% 40.29% 40.29% 40.39% 40.39%

Institutional Investors

FII Holding 15.53% 14.38% 15.61% 16.42% 16.54% 16.83% 14.94% 14.85%
DII Holding 27.82% 29.95% 26.19% 26.04% 26.52% 26.57% 22.47% 22.17%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 11.82% 10.90% 13.10% 12.59% 12.22% 11.88% 7.30% 7.56%
Other Holding 4.62% 4.58% 4.77% 4.64% 4.43% 4.42% 14.90% 15.03%
Shareholder Count 77,278 76,005 83,439 81,742 78,337 79,157 74,976 76,934

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medplus Health Services. Medplus Health Services dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Medplus Health Services.

Medplus Health Services Stock Index Membership - Nifty & Sensex

See which indices include Medplus Health Services stock. Check MEDPLUS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 9 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE Consumer Discretionary Index, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE Consumer Discretionary Index
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED

Medplus Health Services Market Events Screener - Corporate Actions

Get Medplus Health Services corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medplus Health Services stock events that may affect MEDPLUS share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated August 17, 2026, with a record date of August 17, 2026.

It is followed by Quarterly Result Announcement dated July 21, 2026 and Quarterly Result Announcement dated May 20, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-17 2026-08-17 Annual General Meeting NA -15.92%
2026-07-21 2026-07-21 Quarterly Result Announcement NA -2.54%
2026-05-20 2026-05-20 Quarterly Result Announcement NA 12.99%
2026-01-30 2026-01-30 Quarterly Result Announcement NA -4.45%
2025-10-31 2025-10-31 Quarterly Result Announcement NA 0.05%
2025-09-15 2025-09-15 Annual General Meeting NA -8.36%
2025-08-02 2025-08-02 Quarterly Result Announcement NA 7.22%
2025-05-27 2025-05-27 Quarterly Result Announcement NA 33.44%
2025-01-31 2025-01-31 Quarterly Result Announcement NA -13.83%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 3.71%
2024-09-26 2024-09-26 Annual General Meeting NA 1.08%
2023-12-15 2023-12-15 Extraordinary General Meeting NA -9.69%

Medplus Health Services Competitors Screener - Peer Stocks Comparison

Screen MEDPLUS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 4 companies in the Retail sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Medplus Health Services 7,857 37.06 6,964 12.60% 220 41.25
Entero Healthcare Solutions 7,681 46.53 6,610 28.72% 146 54.51
Trimurthi 199 9 -4.17% -2 35.07
Vijaypd Ceutical 129 25.78 104 1.98% 5 50.17

Medplus Health Services Company Announcements - News & Reports Screener

Screen MEDPLUS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated October 4, 2026 and September 10, 2026.

Date Update Actions
2026-10-04 Closure of Trading Window -
2026-10-04 Board Meeting Intimation for The Quarter And Half-Year Ended September 30 2026. -
2026-09-10 Board Comments On Fine Levied By The Exchange -
2026-09-10 Board Meeting Outcome for Outcome Of Board Meeting Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) -
2026-08-26 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-08-26 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-08-21 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-08-21 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-08-18 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-17 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-06 Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-05 Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-01 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-31 Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-07-29 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-07-29 Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. -
2026-07-29 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-07-29 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. -
2026-07-28 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-07-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹644.40, within a 52-week range of ₹644.40 to ₹953.90. The P/E ratio is 37.06 and the P/B ratio is 3.95, with earnings per unit of ₹18.33. Market capitalisation stands at ₹7,856.96 Cr. The company operates in the Retail sector, in the Pharmacy Retail industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.